46th Annual Meeting of Korean Cancer Association &
6th International
Cancer Conference
Program
Updated as of October 22, 2020 It is based on the local time of Seoul, Korea. (UTC/GMT +9:00) |
Date & Time | 11/12(T) 09:40-10:20 | Room | Room A |
---|---|---|---|
Viral and cellular immunotherapeutics for cancer: From research to clinical care
Yuman Fong (City of Hope Medical Center, USA) |
Session Title | Function preserving curable surgery for solid cancer | ||
---|---|---|---|
Date & Time | 11/12(T) 15:20-17:00 | Room | Room B |
1) Is sphincter preservation the best way for rectal cancer? Messages from the ASPIRE study Sung-Bum Kang (Seoul National University College of Medicine) |
|||
2) Microsurgical treatment of lymphedema: Upper extremity and lower extremity Joo Hyoung Kim (Pusan National University School of Medicine) |
|||
3) Function preserving surgery for gastric cancer Ji Yeong An (Sungkyunkwan University School of Medicine) |
Session Title | Young Investigator Symposium 1 | ||
---|---|---|---|
Date & Time | 11/12(T) 13:30-15:10 | Place | Room B |
1) Frontiers in theranostics
Youngju Park (Seoul St. Mary¡¯s Hospital, The Catholic University of Korea) |
|||
2) Spectroscopic tissue scanner for distinguishing between normal mucosa and submucosa, and cancer of stomach Hong Man Yoon (National Cancer Center) |
|||
3) Integrative multi-omics analysis reveals consensus molecular subtypes reflecting distinct clinical phenotypes of hepatocellular carcinoma
Sung Hwan Lee (CHA University School of Medicine) |
|||
4) Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model
Yoo-Young Lee (Samsung Medical Center) |
Session Title | Histology-agnostic treatment approach | ||
---|---|---|---|
Date & Time | 11/12(T) 10:30-12:10 | Place | Room A |
1) NTRK fusion-positive cancers and TRK inhibitor therapy
David S. Hong (MD Anderson Cancer Center, USA) |
|||
2) Targeting the BRAF mutation
Hussein A. Tawbi (MD Anderson Cancer Center, USA) |
|||
3) Analysis of TMB and MSI Status and their treatment outcomes
Sae-Won Han (Seoul National University Hospital) |
|||
4) DNA damage pathways for cancer treatment
Yeon Hee Park (Sungkyunkwan University School of Medicine) |
Session Title | Systems biologic approach to cancer genomics | ||
---|---|---|---|
Date & Time | 11/12(T) 10:30-12:10 | Place | Room B |
1) Oncogenic IRS4 activation in thymic epithelial tumors
Young Seok Ju (Korea Advanced Institute of Science and Technology (KAIST)) |
|||
2) Cross-species oncogenic signatures of breast cancer in canine mammary tumors
Sangwoo Kim (Yonsei University College of Medicine) |
|||
3) Recent update of breast cancer genomics
Wonshik Han (Seoul National University College of Medicine) |
|||
4) Systems biology approach to overcome the therapeutic resistance to multikinase inhibitor
Jae Kyung Won (Seoul National University College of Medicine) |
Session Title | Adolescents and young adults with cancer | ||
---|---|---|---|
Date & Time | 11/12(T) 13:30-15:10 | Place | Room A |
1) The history and current status of AYA oncology
Jung Woo Han (Yonsei University College of Medicine) |
|||
2) Sarcomas in adolescent and young adults (AYA)
Jun Ah Lee (National Cancer Center) |
|||
3) Fertility preservation in female adolescents and young adults with cancers
Jung Ryeol Lee (Seoul National University College of Medicine) |
|||
4) Survivorship of AYA with cancers
Juhee Cho (Sungkyunkwan University ) |
Session Title | Next initiative for cancer immunotherapy | ||
---|---|---|---|
Date & Time | 11/12(T) 15:20-17:00 | Place | Room A |
1) The power of ONE: Immunology in the age of single cell genomics
Ido Amit (Weizmann Institute of Science, Israel) |
|||
2) Utilizing machine intelligence for neoantigen identification
Jung Kyoon Choi (Korea Advanced Institute of Science and Technology (KAIST)) |
|||
3) Machine learning-based immunogenomic analysis of TIME to predict immune directed therapy response in gastric cancer
Jae-Ho Cheong (Yonsei University College of Medicine) |
|||
4) Significance of tumor-specific and non-specific T cells in cancer immunotherapy
Eui-Cheol Shin (Korea Advanced Institute of Science and Technology (KAIST)) |
Session Title | Solidity in gastric cancer treatment: The strong value of ramucirumab for advanced gastric cancer in 2nd line | ||
---|---|---|---|
Date & Time | 11/12(Thu) 08:30-08:50 | Place | Room B |
Hisato Kawakami (Kindai University Faculty of Medicine, Japan)
|
Session Title | The new era of advanced NSCLC treatment: Raising the bar for patient outcome with optimal front-line treatment | ||
---|---|---|---|
Date & Time | 11/12(Thu) 08:50-09:10 | Place | Room B |
Se-Hoon Lee (Sungkyunkwan University School of Medicine)
|
Session Title | At the five-year mark: Conquering cancer and giving life back to patients | ||
---|---|---|---|
Date & Time | 11/12(Thu) 09:10-09:30 | Place | Room B |
Se Hyun Kim (Seoul National University Bundang Hospital)
|
Session Title | More TOMORROWs: Pembrolizumab will double the hope for mNSCLC patients in the 1st line | ||
---|---|---|---|
Date & Time | 11/12(Thu) 12:40-13:20 | Place | Room A |
Hye Ryun Kim (Yonsei University College of Medicine)
|
Date & Time | 11/12(Thu) 08:30-09:30 | Place | Room A |
---|---|---|---|
1) Spatial single-cell RNA sequencing reveals reprogramming of tumor microenvironment according to tumor invasion of diffuse-type gastric cancer
Hoon Hur (Ajou University School of Medicine) |
|||
2) Molecular validation of the 8th edition AJCC cancer staging system in patients with resected pancreatic cancer: Proposal of integrative translational staging system
Sung Hwan Lee (CHA University School of Medicine) |
|||
3) Investigating personalized cancer drug response at the molecular level using DRIM, a web-based integrative system
Minsik Oh (Seoul National University) |
Date & Time | 11/13(F) 09:40-10:20 | Room | Room A | |
---|---|---|---|---|
Introduction | In memory of Professor Waun Ki Hong, a renowned medical oncologist, physician-scientist, and mentor, the KCA established the Waun Ki Hong Memorial Lecture to honor his dedication and seminal research legacy |
|||
Chimeric antigen receptor therapy - Clinical perspective and significance
Carl H. June (University of Pennsylvania School of Medicine, USA) |
Session Title | Recent update of particle radiation therapy | ||
---|---|---|---|
Date & Time | 11/13(F) 15:10-16:50 | Room | Room B |
1) Radiation biology of particle radiation Woong Sub Koom (Yonsei University College of Medicine) |
|||
2) Radiation physics of particle radiation Haksoo Kim (National Cancer Center) |
|||
3) Recent update of proton therapy Do Hoon Lim (Sungkyunkwan University School of Medicine) |
|||
4) Recent update of carbon ion radiotherapy (CIRT) Hong-Gyun Wu (Seoul National University College of Medicine) |
Session Title | Young Investigator Symposium II | ||
---|---|---|---|
Date & Time | 11/13(F) 13:20-15:00 | Place | Room B |
1) Tumor metastasis to lymph node requires metabolic reprogramming toward fatty acid oxidation
Choong-kun Lee (Yonsei University College of Medicine) |
|||
2) Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1 Jong-ho Cha (Inha University School of Medicine) |
|||
3) Immunologic response to radiotherapy in hepatocellular carcinoma
Yoon Sun Choi (Inje University Busan Paik Hospital) |
|||
4) Application of artificial intelligence in colorectal cancer research
Eun Kyung Choe (Seoul National University College of Medicine) |
Session Title | Recent update of systemic therapy in gynecologic cancers | ||
---|---|---|---|
Date & Time | 11/13(F) 10:30-12:10 | Place | Room A |
1) Role of Notch signaling in tumor microenvironment
Kyung-Hee Chun (Yonsei University College of Medicine) |
|||
2) PARPi in epithelial ovarian cancer: Current and future
Maria Lee (Seoul National University College of Medicine) |
|||
3) Preclinical drug development: Translating basic research into clinical practice
Youn Jin Choi (The Catholic University of Korea College of Medicine) |
|||
4) IO drugs in gynecological cancer: Current and future
Jin Young Kim (Keimyung University School of Medicine) |
Session Title | Multidisciplinary translational conference (Part 1 & 2) | ||
---|---|---|---|
Date & Time | 11/13(F) 10:30-12:10 | Place | Room B |
1) Development of an NGS-based prognostic tool with clinical utility
Han-Byoel Lee (Seoul National University College of Medicine) |
|||
2) Algorithm modelling using gene expression data
Sungroh Yoon (Seoul National University College of Engineering) |
|||
3) Multi-omics data analysis to solve clinical unmet needs of advanced cancer
Se-Hoon Lee (Sungkyunkwan University School of Medicine) Semin Lee (Ulsan National Institute of Science and Technology) |
Session Title | Resistance mechanisms and new target discovery | ||
---|---|---|---|
Date & Time | 11/13(F) 13:20-15:00 | Place | Room A |
1) Resistance to immune checkpoint inhibitors: Next steps for new approaches
Michele Woei Ling Teng (QIMR Berghofer Medical Research Institute, Australia) |
|||
2) Overcoming EGFR TKIs resistance to EGFR mutant NSCLC
James Chih-Hsin Yang (National Taiwan University Cancer Center, Taiwan) |
|||
3) Strategies to overcome trastuzumab resistance in HER2 overexpressing breast cancers: Focus on new data from clinical trials
Jee Hyun Kim (Seoul National University College of Medicine) |
|||
4) Understanding and overcoming the mechanisms of castration-resistance in prostate cancer
Inkeun Park (Gachon University College of Medicine) |
Session Title | ³Ä¡¼º ¾ÏȯÀÚÀÇ Ä¡·á¸¦ À§ÇÑ Á¦µµ¿Í ±Þ¿©Á¤Ã¥ | ||
---|---|---|---|
Date & Time | 11/13(F) 15:10-16:50 | Place | Room A |
1) ³Ä¡¼º ¾ÏȯÀÚÀÇ Ä¡·á¸¦ À§ÇÑ Á¦µµ¿Í ±Þ¿©Á¤Ã¥ (ÀÓ»ó°¡ Ãø¸é)
±è¿È« (°í·ÁÀÇ´ë) |
|||
2) ³Ä¡¼º ¾ÏȯÀÚÀÇ Ä¡·á¸¦ À§ÇÑ Á¦µµ
¾È¹Ì·É (½ÄÇ°ÀǾàÇ°¾ÈÀüÆò°¡¿ø) |
|||
3) ³Ä¡¼º ¾ÏȯÀÚÀÇ Ä¡·á¸¦ À§ÇÑ ±Þ¿©Á¤Ã¥
ÇϼºÈñ (°Ç°º¸Çè½É»çÆò°¡¿ø) |
|||
4) ¾Ï°ü·Ã º¸°ÇÀÇ·á ºòµ¥ÀÌÅÍ ¹× real-world data È°¿ë - ´ëÇÑ°£¾ÏÇÐȸ-Á߾Ӿϵî·Ïº»ºÎ °£¾Ïµî·Ï»ç¾÷ÀÇ »ç·Ê¸¦ Áß½ÉÀ¸·Î ÀÌÁ¤ÈÆ (¼¿ïÀÇ´ë) |
|||
5) Panel Discussion
|
Session Title | Expanded benefit for 1L ES-SCLC patients with Tecentriq combination therapy | ||
---|---|---|---|
Date & Time | 11/13(Fri) 12:40-13:10 | Place | Room A |
Min Hee Hong (Yonsei University College of Medicine)
|
Session Title | Liposomal irinotecan in metastatic pancreatic cancer: Asian and Korean experiences | ||
---|---|---|---|
Date & Time | 11/13(Fri) 12:40-13:10 | Place | Room B |
Changhoon Yoo (University of Ulsan College of Medicine)
|
Date & Time | 11/13(Fri) 08:30-09:30 | Place | Room A |
---|---|---|---|
1) Engineering and characterization of oncolytic vaccinia virus expressing truncated herpes simplex virus thymidine kinase
S M BAKHTIAR UL ISLAM (Pusan National University) |
|||
2) A proteomic landscape of precancerous gastric lesions and gastric cancer in high-risk population
Xue Li (Peking University Cancer Hospital & Institute, China) |
|||
3) Automated detection improves identification of oligometastatic disease and prevention of missing metastases during metastasis-directed therapy
Jason Joon Bock Lee (Yonsei University College of Medicine) |
|||
4) Single patient classifier as a prognostic biomarker for pT1N1 gastric cancer: Results from two large cohorts in Korea
Yoon Young Choi (CHA University College of Medicine) |
|||
5) Functional bypass of cell cycle entry checkpoints by MYC T58A mutation in germinal center-derived lymphomas
Jongkuen Lee (Icahn School of Medicine at Mount Sinai, USA) |
|||
6) Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01)
Chan Woo Wee (SMG-SNU Boramae Medical Center) |
Date & Time | 11/13(Fri) 08:30-09:30 | Place | Room B |
---|---|---|---|
1) Development of the prediction model based on radiation response and mutational profile revealed from targeted gene-sequencing using FIRST cancer panel
Bum-Sup Jang (Seoul National University Bundang Hospital) |
|||
2) Clinical usage for rare cancer(NUT carcinoma) diagnosis and guidance of potential targeted therapies
Sungbin An (Sungkyunkwan University) |
|||
3) Dacomitinib vs gefitinib in first-line treatment of advanced epidermal growth factor receptor-activating mutation-positive (EGFR+) non-small cell lung cancer (NSCLC) (ARCHER 1050): Korean subset
Dong-Wan Kim (Seoul National University College of Medicine) |
|||
4) Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux
Chul-Ho Kim (Ajou University School of Medicine) |
|||
5) Lung cancer exosome specific protein 1 (LESP-1) as a potential biomarker for early diagnosis and therapeutic target for non-small cell lung cancer
Byeong Hyeon Choi (Korea University College of Medicine) |
|||
6) Cigarette smoking is associated with increased risk of malignant gliomas: A nationwide population-based cohort study
Seung Ho Yang (The Catholic University of Korea College of Medicine) |